APO Research
Talk to an analyst

APO RESEARCH · REPORT

Breast-Conserving Surgery

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.

Selected research

Market Analysis & Forecast

Global Breast-Conserving Surgery Market Analysis and Forecast 2026-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchBreast-Conserving Surgery Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Breast-Conserving Surgery Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Breast-Conserving Surgery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Breast-Conserving Surgery Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Breast-Conserving Surgery Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.

The classification of Breast-Conserving Surgery includes Lumpectomy Systems and Lumpectomy Surgical Tools.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 53.14% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 22%, Asia-Pacific is also an important sales region for the Breast-Conserving Surgery.

Market competition is intense. Hologic, BD, Danaher, Carl Zeiss Meditech, Merit Medical, Argon Medical Devices, etc. are the leaders of the industry.

Report Includes

This report presents an overview of global market for Breast-Conserving Surgery, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Breast-Conserving Surgery, also provides the revenue of main regions and countries. Of the upcoming market potential for Breast-Conserving Surgery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Breast-Conserving Surgery revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Breast-Conserving Surgery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Breast-Conserving Surgery revenue, projected growth trends, production technology, application and end-user industry.

Breast-Conserving Surgery Segment by Company

Hologic

BD

Danaher

Carl Zeiss Meditech

Merit Medical

Argon Medical Devices

Sanarus

Endomagnetics

SOMATEX Medical

Ranfac

STERYLAB

Breast-Conserving Surgery Segment by Type

Lumpectomy Systems

Lumpectomy Surgical Tools

Breast-Conserving Surgery Segment by Application

Hospitals

Ambulatory Surgical Centers

Breast-Conserving Surgery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast-Conserving Surgery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Breast-Conserving Surgery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast-Conserving Surgery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Breast-Conserving Surgery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Breast-Conserving Surgery company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breast-Conserving Surgery revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Breast-Conserving Surgery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lumpectomy Systems Major Player Table 3. Lumpectomy Surgical Tools Major Player Table 4. Global Breast-Conserving Surgery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Ambulatory Surgical Centers Major Player Table 7. Breast-Conserving Surgery Industry Trends Table 8. Breast-Conserving Surgery Industry Drivers Table 9. Breast-Conserving Surgery Industry Opportunities and Challenges Table 10. Breast-Conserving Surgery Industry Restraints Table 11. Global Breast-Conserving Surgery Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Breast-Conserving Surgery Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Breast-Conserving Surgery Market Share by Region (2021-2026) Table 14. Global Breast-Conserving Surgery Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Breast-Conserving Surgery Market Share by Region (2027-2032) Table 16. Global Breast-Conserving Surgery Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Breast-Conserving Surgery Revenue Market Share by Players (2021-2026) Table 18. Global Breast-Conserving Surgery Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Breast-Conserving Surgery Key Players Headquarters & Area Served Table 20. Global Breast-Conserving Surgery Players, Product Type & Application Table 21. Global Breast-Conserving Surgery Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Breast-Conserving Surgery by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Breast-Conserving Surgery Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Breast-Conserving Surgery Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Breast-Conserving Surgery Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Breast-Conserving Surgery Revenue Market Share by Type (2021-2026) Table 28. Global Breast-Conserving Surgery Revenue Market Share by Type (2027-2032) Table 29. Global Breast-Conserving Surgery Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Breast-Conserving Surgery Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Breast-Conserving Surgery Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Breast-Conserving Surgery Revenue Market Share by Application (2021-2026) Table 33. Global Breast-Conserving Surgery Revenue Market Share by Application (2027-2032) Table 34. Hologic Company Information Table 35. Hologic Business Overview Table 36. Hologic Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Hologic Breast-Conserving Surgery Product Portfolio Table 38. Hologic Recent Development Table 39. BD Company Information Table 40. BD Business Overview Table 41. BD Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. BD Breast-Conserving Surgery Product Portfolio Table 43. BD Recent Development Table 44. Danaher Company Information Table 45. Danaher Business Overview Table 46. Danaher Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Danaher Breast-Conserving Surgery Product Portfolio Table 48. Danaher Recent Development Table 49. Carl Zeiss Meditech Company Information Table 50. Carl Zeiss Meditech Business Overview Table 51. Carl Zeiss Meditech Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Carl Zeiss Meditech Breast-Conserving Surgery Product Portfolio Table 53. Carl Zeiss Meditech Recent Development Table 54. Merit Medical Company Information Table 55. Merit Medical Business Overview Table 56. Merit Medical Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Merit Medical Breast-Conserving Surgery Product Portfolio Table 58. Merit Medical Recent Development Table 59. Argon Medical Devices Company Information Table 60. Argon Medical Devices Business Overview Table 61. Argon Medical Devices Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Argon Medical Devices Breast-Conserving Surgery Product Portfolio Table 63. Argon Medical Devices Recent Development Table 64. Sanarus Company Information Table 65. Sanarus Business Overview Table 66. Sanarus Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Sanarus Breast-Conserving Surgery Product Portfolio Table 68. Sanarus Recent Development Table 69. Endomagnetics Company Information Table 70. Endomagnetics Business Overview Table 71. Endomagnetics Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Endomagnetics Breast-Conserving Surgery Product Portfolio Table 73. Endomagnetics Recent Development Table 74. SOMATEX Medical Company Information Table 75. SOMATEX Medical Business Overview Table 76. SOMATEX Medical Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. SOMATEX Medical Breast-Conserving Surgery Product Portfolio Table 78. SOMATEX Medical Recent Development Table 79. Ranfac Company Information Table 80. Ranfac Business Overview Table 81. Ranfac Breast-Conserving Surgery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Ranfac Breast-Conserving Surgery Product Portfolio Table 83. Ranfac Recent Development Table 84. STERYLAB Company Information Table 85. STERYLAB Business Overview Table 86. STERYLAB Breast-Conserving Surgery Sales (K Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 87. STERYLAB Breast-Conserving Surgery Product Portfolio Table 88. STERYLAB Recent Development Table 89. North America Breast-Conserving Surgery Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Breast-Conserving Surgery Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Breast-Conserving Surgery Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Breast-Conserving Surgery Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Breast-Conserving Surgery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Breast-Conserving Surgery Revenue by Country (2021-2026) & (US$ Million) Table 95. North America Breast-Conserving Surgery Revenue by Country (US$ Million) & (2027-2032) Table 96. Europe Breast-Conserving Surgery Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Breast-Conserving Surgery Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Breast-Conserving Surgery Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Breast-Conserving Surgery Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Breast-Conserving Surgery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Breast-Conserving Surgery Revenue by Country (2021-2026) & (US$ Million) Table 102. Europe Breast-Conserving Surgery Revenue by Country (US$ Million) & (2027-2032) Table 103. China Breast-Conserving Surgery Revenue by Type (2021-2026) & (US$ Million) Table 104. China Breast-Conserving Surgery Revenue by Type (2027-2032) & (US$ Million) Table 105. China Breast-Conserving Surgery Revenue by Application (2021-2026) & (US$ Million) Table 106. China Breast-Conserving Surgery Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Breast-Conserving Surgery Revenue by Type (2021-2026) & (US$ Million) Table 108. Asia Breast-Conserving Surgery Revenue by Type (2027-2032) & (US$ Million) Table 109. Asia Breast-Conserving Surgery Revenue by Application (2021-2026) & (US$ Million) Table 110. Asia Breast-Conserving Surgery Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Breast-Conserving Surgery Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Breast-Conserving Surgery Revenue by Region (US$ Million) & (2021-2026) Table 113. Asia Breast-Conserving Surgery Revenue by Region (US$ Million) & (2027-2032) Table 114. SAMEA Breast-Conserving Surgery Revenue by Type (2021-2026) & (US$ Million) Table 115. SAMEA Breast-Conserving Surgery Revenue by Type (2027-2032) & (US$ Million) Table 116. SAMEA Breast-Conserving Surgery Revenue by Application (2021-2026) & (US$ Million) Table 117. SAMEA Breast-Conserving Surgery Revenue by Application (2027-2032) & (US$ Million) Table 118. SAMEA Breast-Conserving Surgery Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. SAMEA Breast-Conserving Surgery Revenue by Country (2021-2026) & (US$ Million) Table 120. SAMEA Breast-Conserving Surgery Revenue by Country (US$ Million) & (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Breast-Conserving Surgery Image Figure 2. Global Breast-Conserving Surgery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Breast-Conserving Surgery Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lumpectomy Systems Image Figure 5. Lumpectomy Surgical Tools Image Figure 6. Global Breast-Conserving Surgery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Breast-Conserving Surgery Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Ambulatory Surgical Centers Image Figure 10. Global Breast-Conserving Surgery Market Size (US$ Million) & (2021-2032) Figure 11. Global Breast-Conserving Surgery Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Breast-Conserving Surgery Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Breast-Conserving Surgery Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Breast-Conserving Surgery Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Breast-Conserving Surgery Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Breast-Conserving Surgery Revenue Market Share by Type (2021-2032) Figure 18. Global Breast-Conserving Surgery Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Breast-Conserving Surgery Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Breast-Conserving Surgery Revenue Market Share by Application (2021-2032) Figure 21. North America Breast-Conserving Surgery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Breast-Conserving Surgery Revenue Share by Type (2021-2032) Figure 23. North America Breast-Conserving Surgery Revenue Share by Application (2021-2032) Figure 24. North America Breast-Conserving Surgery Revenue Share by Country (2021-2032) Figure 25. United States Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Breast-Conserving Surgery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Breast-Conserving Surgery Revenue Share by Type (2021-2032) Figure 30. Europe Breast-Conserving Surgery Revenue Share by Application (2021-2032) Figure 31. Europe Breast-Conserving Surgery Revenue Share by Country (2021-2032) Figure 32. Germany Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Breast-Conserving Surgery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Breast-Conserving Surgery Revenue Share by Type (2021-2032) Figure 42. China Breast-Conserving Surgery Revenue Share by Application (2021-2032) Figure 43. Asia Breast-Conserving Surgery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Breast-Conserving Surgery Revenue Share by Type (2021-2032) Figure 45. Asia Breast-Conserving Surgery Revenue Share by Application (2021-2032) Figure 46. Asia Breast-Conserving Surgery Revenue Share by Region (2021-2032) Figure 47. Japan Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Breast-Conserving Surgery Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Breast-Conserving Surgery Revenue Share by Type (2021-2032) Figure 55. SAMEA Breast-Conserving Surgery Revenue Share by Application (2021-2032) Figure 56. SAMEA Breast-Conserving Surgery Revenue Share by Country (2021-2032) Figure 57. Brazil Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Breast-Conserving Surgery Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Lumpectomy Systems
  • Lumpectomy Surgical Tools
Applications
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Hologic
  • BD
  • Danaher
  • Carl Zeiss Meditech
  • Merit Medical
  • Argon Medical Devices
  • Sanarus
  • Endomagnetics
  • SOMATEX Medical
  • Ranfac
  • STERYLAB

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Breast-Conserving Surgery Market by Type
  3. 1.2.1 Global Breast-Conserving Surgery Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lumpectomy Systems
  5. 1.2.3 Lumpectomy Surgical Tools
  6. 1.3 Breast-Conserving Surgery Market by Application
  7. 1.3.1 Global Breast-Conserving Surgery Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Ambulatory Surgical Centers
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Breast-Conserving Surgery Market Dynamics
  1. 2.1 Breast-Conserving Surgery Industry Trends
  2. 2.2 Breast-Conserving Surgery Industry Drivers
  3. 2.3 Breast-Conserving Surgery Industry Opportunities and Challenges
  4. 2.4 Breast-Conserving Surgery Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Breast-Conserving Surgery Market Perspective (2021-2032)
  2. 3.2 Global Breast-Conserving Surgery Growth Trends by Region
  3. 3.2.1 Global Breast-Conserving Surgery Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Breast-Conserving Surgery Market Size by Region (2021-2026)
  5. 3.2.3 Global Breast-Conserving Surgery Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Breast-Conserving Surgery Revenue by Players
  2. 4.1.1 Global Breast-Conserving Surgery Revenue by Players (2021-2026)
  3. 4.1.2 Global Breast-Conserving Surgery Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Breast-Conserving Surgery Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Breast-Conserving Surgery Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Breast-Conserving Surgery Key Players Headquarters & Area Served
  7. 4.4 Global Breast-Conserving Surgery Players, Product Type & Application
  8. 4.5 Global Breast-Conserving Surgery Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Breast-Conserving Surgery Market CR5 and HHI
  11. 4.6.3 2025 Breast-Conserving Surgery Tier 1, Tier 2, and Tier 3
5 Breast-Conserving Surgery Market Size by Type
  1. 5.1 Global Breast-Conserving Surgery Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Breast-Conserving Surgery Revenue by Type (2021-2032)
  3. 5.3 Global Breast-Conserving Surgery Revenue Market Share by Type (2021-2032)
6 Breast-Conserving Surgery Market Size by Application
  1. 6.1 Global Breast-Conserving Surgery Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Breast-Conserving Surgery Revenue by Application (2021-2032)
  3. 6.3 Global Breast-Conserving Surgery Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Hologic
  2. 7.1.1 Hologic Company Information
  3. 7.1.2 Hologic Business Overview
  4. 7.1.3 Hologic Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Hologic Breast-Conserving Surgery Product Portfolio
  6. 7.1.5 Hologic Recent Developments
  7. 7.2 BD
  8. 7.2.1 BD Company Information
  9. 7.2.2 BD Business Overview
  10. 7.2.3 BD Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BD Breast-Conserving Surgery Product Portfolio
  12. 7.2.5 BD Recent Developments
  13. 7.3 Danaher
  14. 7.3.1 Danaher Company Information
  15. 7.3.2 Danaher Business Overview
  16. 7.3.3 Danaher Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Danaher Breast-Conserving Surgery Product Portfolio
  18. 7.3.5 Danaher Recent Developments
  19. 7.4 Carl Zeiss Meditech
  20. 7.4.1 Carl Zeiss Meditech Company Information
  21. 7.4.2 Carl Zeiss Meditech Business Overview
  22. 7.4.3 Carl Zeiss Meditech Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Carl Zeiss Meditech Breast-Conserving Surgery Product Portfolio
  24. 7.4.5 Carl Zeiss Meditech Recent Developments
  25. 7.5 Merit Medical
  26. 7.5.1 Merit Medical Company Information
  27. 7.5.2 Merit Medical Business Overview
  28. 7.5.3 Merit Medical Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Merit Medical Breast-Conserving Surgery Product Portfolio
  30. 7.5.5 Merit Medical Recent Developments
  31. 7.6 Argon Medical Devices
  32. 7.6.1 Argon Medical Devices Company Information
  33. 7.6.2 Argon Medical Devices Business Overview
  34. 7.6.3 Argon Medical Devices Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Argon Medical Devices Breast-Conserving Surgery Product Portfolio
  36. 7.6.5 Argon Medical Devices Recent Developments
  37. 7.7 Sanarus
  38. 7.7.1 Sanarus Company Information
  39. 7.7.2 Sanarus Business Overview
  40. 7.7.3 Sanarus Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sanarus Breast-Conserving Surgery Product Portfolio
  42. 7.7.5 Sanarus Recent Developments
  43. 7.8 Endomagnetics
  44. 7.8.1 Endomagnetics Company Information
  45. 7.8.2 Endomagnetics Business Overview
  46. 7.8.3 Endomagnetics Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Endomagnetics Breast-Conserving Surgery Product Portfolio
  48. 7.8.5 Endomagnetics Recent Developments
  49. 7.9 SOMATEX Medical
  50. 7.9.1 SOMATEX Medical Company Information
  51. 7.9.2 SOMATEX Medical Business Overview
  52. 7.9.3 SOMATEX Medical Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  53. 7.9.4 SOMATEX Medical Breast-Conserving Surgery Product Portfolio
  54. 7.9.5 SOMATEX Medical Recent Developments
  55. 7.10 Ranfac
  56. 7.10.1 Ranfac Company Information
  57. 7.10.2 Ranfac Business Overview
  58. 7.10.3 Ranfac Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Ranfac Breast-Conserving Surgery Product Portfolio
  60. 7.10.5 Ranfac Recent Developments
  61. 7.11 STERYLAB
  62. 7.11.1 STERYLAB Company Information
  63. 7.11.2 STERYLAB Business Overview
  64. 7.11.3 STERYLAB Breast-Conserving Surgery Revenue and Gross Margin (2021-2026)
  65. 7.11.4 STERYLAB Breast-Conserving Surgery Product Portfolio
  66. 7.11.5 STERYLAB Recent Developments
8 North America
  1. 8.1 North America Breast-Conserving Surgery Revenue (2021-2032)
  2. 8.2 North America Breast-Conserving Surgery Revenue by Type (2021-2032)
  3. 8.2.1 North America Breast-Conserving Surgery Revenue by Type (2021-2026)
  4. 8.2.2 North America Breast-Conserving Surgery Revenue by Type (2027-2032)
  5. 8.3 North America Breast-Conserving Surgery Revenue Share by Type (2021-2032)
  6. 8.4 North America Breast-Conserving Surgery Revenue by Application (2021-2032)
  7. 8.4.1 North America Breast-Conserving Surgery Revenue by Application (2021-2026)
  8. 8.4.2 North America Breast-Conserving Surgery Revenue by Application (2027-2032)
  9. 8.5 North America Breast-Conserving Surgery Revenue Share by Application (2021-2032)
  10. 8.6 North America Breast-Conserving Surgery Revenue by Country
  11. 8.6.1 North America Breast-Conserving Surgery Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Breast-Conserving Surgery Revenue by Country (2021-2026)
  13. 8.6.3 North America Breast-Conserving Surgery Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Breast-Conserving Surgery Revenue (2021-2032)
  2. 9.2 Europe Breast-Conserving Surgery Revenue by Type (2021-2032)
  3. 9.2.1 Europe Breast-Conserving Surgery Revenue by Type (2021-2026)
  4. 9.2.2 Europe Breast-Conserving Surgery Revenue by Type (2027-2032)
  5. 9.3 Europe Breast-Conserving Surgery Revenue Share by Type (2021-2032)
  6. 9.4 Europe Breast-Conserving Surgery Revenue by Application (2021-2032)
  7. 9.4.1 Europe Breast-Conserving Surgery Revenue by Application (2021-2026)
  8. 9.4.2 Europe Breast-Conserving Surgery Revenue by Application (2027-2032)
  9. 9.5 Europe Breast-Conserving Surgery Revenue Share by Application (2021-2032)
  10. 9.6 Europe Breast-Conserving Surgery Revenue by Country
  11. 9.6.1 Europe Breast-Conserving Surgery Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Breast-Conserving Surgery Revenue by Country (2021-2026)
  13. 9.6.3 Europe Breast-Conserving Surgery Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Breast-Conserving Surgery Revenue (2021-2032)
  2. 10.2 China Breast-Conserving Surgery Revenue by Type (2021-2032)
  3. 10.2.1 China Breast-Conserving Surgery Revenue by Type (2021-2026)
  4. 10.2.2 China Breast-Conserving Surgery Revenue by Type (2027-2032)
  5. 10.3 China Breast-Conserving Surgery Revenue Share by Type (2021-2032)
  6. 10.4 China Breast-Conserving Surgery Revenue by Application (2021-2032)
  7. 10.4.1 China Breast-Conserving Surgery Revenue by Application (2021-2026)
  8. 10.4.2 China Breast-Conserving Surgery Revenue by Application (2027-2032)
  9. 10.5 China Breast-Conserving Surgery Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Breast-Conserving Surgery Revenue (2021-2032)
  2. 11.2 Asia Breast-Conserving Surgery Revenue by Type (2021-2032)
  3. 11.2.1 Asia Breast-Conserving Surgery Revenue by Type (2021-2026)
  4. 11.2.2 Asia Breast-Conserving Surgery Revenue by Type (2027-2032)
  5. 11.3 Asia Breast-Conserving Surgery Revenue Share by Type (2021-2032)
  6. 11.4 Asia Breast-Conserving Surgery Revenue by Application (2021-2032)
  7. 11.4.1 Asia Breast-Conserving Surgery Revenue by Application (2021-2026)
  8. 11.4.2 Asia Breast-Conserving Surgery Revenue by Application (2027-2032)
  9. 11.5 Asia Breast-Conserving Surgery Revenue Share by Application (2021-2032)
  10. 11.6 Asia Breast-Conserving Surgery Revenue by Country
  11. 11.6.1 Asia Breast-Conserving Surgery Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Breast-Conserving Surgery Revenue by Country (2021-2026)
  13. 11.6.3 Asia Breast-Conserving Surgery Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Breast-Conserving Surgery Revenue (2021-2032)
  2. 12.2 SAMEA Breast-Conserving Surgery Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Breast-Conserving Surgery Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Breast-Conserving Surgery Revenue by Type (2027-2032)
  5. 12.3 SAMEA Breast-Conserving Surgery Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Breast-Conserving Surgery Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Breast-Conserving Surgery Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Breast-Conserving Surgery Revenue by Application (2027-2032)
  9. 12.5 SAMEA Breast-Conserving Surgery Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Breast-Conserving Surgery Revenue by Country
  11. 12.6.1 SAMEA Breast-Conserving Surgery Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Breast-Conserving Surgery Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Breast-Conserving Surgery Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst